Molecular analyses of the interactions between human NK receptors and their HLA ligands

Human Immunology

Volumn 61, Issue 1, 2000, Pages 28-38

  Valés Gómez, Mar ^a   Reyburn, Hugh ^b   Strominger, Jack ^a  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

BIAcore; HLA; NK receptors

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN RECOGNITION; ARTICLE; LIGAND BINDING; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; TARGET CELL;

ANTIGENS, CD; ANTIGENS, CD94; DIMERIZATION; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIGANDS; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 0342905008     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00159-7     Document Type: Article

References (91)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol. 47:1989;187.
2. Unanue E.R. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immun Rev. 158:1997;11.
3. Scott P., Trinchieri G. The role of natural killer cells in host-parasite interactions. Curr Opin Immunol. 7:1995;34.
4. Biron C.A. Activation and function of natural killer cell response during viral infections. Curr Opin Immunol. 9:1997;24.
5. Lanier L.L., Corliss B., Phillips J.H. Arousal and inhibition of human NK cells. Immunol Rev. 155:1997;145.
6. Carbone E., Ruggiero G., Terrazzano G., Palomba C., Manzo C., Fontana S., Spits H., Kärre K., Zappacosta S. A new mechanism of NK cell cytotoxicity activation the CD40-CD40 ligand interaction . J Exp Med. 185:1997;2053.
7. Helander T.S., Carpen O., Turunen O., Kovanen P.E., Vaheri A., Timonen T. ICAM-2 redistributed by ezrin as a target for killer cells. Nature. 382:1996;265.
8. Leibson P.J. Signal transduction during natural killer cell activation inside the mind of a killer . Immunity. 6:1997;655.
9. Ryan J.C., Niemi E.C., Nakamura M.C., Seaman W.E. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J Exp Med. 181:1995;1911.
10. Moretta A., Sivori S., Vitale M., Pende D., Morelli L., Augugliaro R., Bottino C., Moretta L. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med. 182:1995;875.
11. Houchins J.P., Lanier L.L., Niemi E.C., Phillips J.H., Ryan J.C. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol. 158:1997;3603.
12. Perez Villar J.J., Melero I., Rodriguez A., Carretero M., Aramburu J., Sivori S., Orengo A.M., Moretta A., Lopez-Botet M. Functional ambivalence of the Kp43 (CD94) NK cell associated surface antigen. J Immunol. 154:1995;5779.
13. Cantoni C., Biassoni R., Pende D., Sivori S., Accame L., Pareti L., Semenzato G., Moretta L., Moretta A., Bottino C. The activating form of CD94 receptor complex CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene . Eur J Immunol. 28:1998;327.
14. Sivori S., Vitale M., Morelli L., Sanseverino L., Augugliaro R., Bottino C., Moretta L., Moretta A. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med. 186:1997;1129.
15. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro S., Augugliaro R., Moretta L., Moretta A. Nkp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility-restricted tumour cell lysis. J Exp Med. 187:1998;2065.
16. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., Moretta L. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol. 14:1996;619.
17. Lanier L.L. NK cell receptors. Ann Rev Immunol. 16:1998;359.
18. Ljunggren H.-G., Karre K. In search of the 'missing self' MHC molecules and NK recognition . Immunol Today. 11:1990;237.
19. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., Hsu M.L. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 7:1997;273.
20. Borges L., Hsu M.L., Fanger N., Kubin M., Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol. 159:1997;5192.
21. Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J., Angman L., Cella M., Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 186:1997;1809.
22. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med. 187:1998;813.
23. Braud V.M., Allan D.C., O'Callaghan C.A., Soderstrom K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795.
24. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA. 95:1998;5199.
25. Moretta A., Tambussi G., Bottino C., Tripodi G., Merli A., Ciccone E., Pantaleo G., Moretta L. A novel surface antigen expressed by a subset of human CD3-CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. J Exp Med. 171:1990;695.
26. Moretta A., Bottino C., Pende D., Tripodi G., Tambussi G., Viale O., Orengo A., Barbaresi M., Merli A., Ciccone E., et al. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition . J Exp Med. 172:1990;1589.
27. Vitale M., Sivori S., Pende D., Moretta A., Moretta L. Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells. Proc Natl Acad Sci USA. 91:1995;3536.
28. Moretta A., Vitale M., Bottino C., Orengo A.M., Morelli L., Augugliaro R., Barbaresi M., Ciccone E., Moretta L. p58 molecules as putative receptors for major-histocompatibility complex (MHC) class I molecules in human natural killer cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med. 178:1993;597.
29. Colonna M., Samaridis J. Cloning of immunoglobulin superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 268:1995;405.
30. Wagtmann N., Biassoni R., Cantoni C., Verdiani S., Malnati M.S., Vitale M., Bottino C., Moretta L., Moretta A., Long E.O. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intra-cellular domains. Immunity. 2:1995;439.
31. D'Andrea A., Chang C., Franz-Bacon K., McClanahan T., Phillips J.H., Lanier L.L. Molecular cloning of NKB1 a natural killer cell receptor for HLA-B allotypes . J Immunol. 155:1995;2306.
32. Wagtmann N., Rajagopalan S., Winter C.C., Peruzzi M., Long E.O. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and functional transfer. Immunity. 3:1995;801.
33. Fan Q.O.R., Garboczi D.C., Winter C.C., Wagtmann N., Long E.O., Wiley D.C. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc Natl Acad Sci USA. 93:1996;7178.
34. Valés Gómez M, Reyburn HT, Mandelboim M, Strominger JL: Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. Immunity 9:337, 1998, and correction Immunity 9:892, 1998.
35. Valés Gómez M, Reyburn HT, Mandelboim M, Strominger JL: Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. Immunity 9:337, 1998, and correction Immunity 9:892, 1998.
36. Long E.O., Colonna M., Lanier L.L. Inhibitory MHC class I receptors on NK and T cells a standard nomenclature . Immunol Today. 17:1996;100. [letter].
37. Renard V., Cambiaggi A., Vely F., Blery M., Olcese L., Olivero S., Bouchet M., Vivier E. Transduction of cytotoxic signals in natural killer cells a general model of fine tuning between activatory and inhibitory pathways in lymphocytes . Immunol Rev. 155:1997;205.
38. Burshtyn D.N., Scharenberg A.M., Wagtmann N., Rajagopalan S., Berrada K., Yi T., Kinet J.-P., Long E.O. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity. 4:1996;77.
39. Olcese L., Lang P., Vely F., Cambiaggi A., Marguet D., Blery M., Hippen K.L., Biassoni R., Moretta A., Moretta L., Cambier J.C., Vivier E. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol. 156:1996;4531.
40. Fry A.M., Lanier L.L., Weiss A. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J Exp Med. 184:1996;295.
41. Campbell K.S., Dessing M., Lopez-Botet M., Cella M., Colonna M. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med. 184:1996;93.
42. Olcese L., Cambiaggi A., Semenzato G., Bottino C., Moretta A., Vivier E. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol. 158:1997;5083.
43. Lanier L.L., Corliss B.C., Wu J., Leong C., Phillips J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 391:1998;703.
44. Biassoni R., Cantoni C., Falco M., Verdiani S., Bottino C., Vitale M., Conte R., Poggi A., Moretta A., Moretta L. The human leukocyte antigen (HLA)-C-specific 'activatory' or 'inhibitory' natural killer cell receptors display highly homologous extracellulare domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med. 184:1996;645.
45. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., Phillips J.H., Lanier L.L., Parham P. Funtionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity. 7:1997;739.
46. Mandelboim O., Davis D.M., Reyburn H.T., Vales-Gomez M., Sheu E.G., Pazmany L., Strominger J.L. Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins. Science. 274:1996;2097.
47. Gumperz J.E., Valiante N.M., Parhap P., Lanier L.L., Tyan D. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype. J Exp Med. 183:1996;1817.
48. Mandelboim O., Reyburn H.T., Vales-Gomez M., Pazmany L., Colonna M., Borsellino G., Strominger J.L. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med. 184:1996;913.
49. Fan Q.R., Mosyak L., Winter C.C., Wagtmann N., Long E.O., Wiley D.C. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature. 389:1997;96.
50. Maenaki K, Juji T, Stuart DI, Jones EY: Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. Structure, 1999.
51. Snyder G.A., Brooks A.G., Sun P.D. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2. Proc Natl Acad Sci USA. 96:1999;3864.
52. Winter C.C., Long E.O. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol. 158:1997;4026.
53. Biassoni R., Pessino A., Malaspina A., Cantoni C., Bottino C., Sivori S., Moretta L., Moretta A. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol. 27:1997;3095.
54. Mandelboim O., Reyburn H.T., Sheu E.G., Vales-Gomez M., Davis D.M., Pazmany L., Strominger J.L. The binding sitre of NK receptors on HLA-C molecules. Immunity. 6:1997;341.
55. Gumperz J.E., Litwin V., Phillips J.H., Lanier L.L., Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med. 181:1995;1133.
56. Gumperz J.E., Barber L.D., Valiante N.M., Percival L., Phillips H.J., Lanier L.L., Parham P. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol. 158:1997;5237.
57. Valés-Gómez M., Reyburn H.T., Erskine R.A., Strominger J.L. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc Natl Acad Sci USA. 95:1998;14326.
58. Bell G.I. Models for the specific adhesion of cells to cells. Science. 200:1978;618.
59. Colonna M., Borsellino G., Falco M., Ferrara G.B., Strominger J.L. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci USA. 90:1993;12000.
60. Winter C.C., Gumperz J.E., Parham P., Long E.O., Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol. 161:1998;571.
61. van der Merwe P.A., Bodian D.L., Daenke S., Linsley P., Davis S.J. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J Exp Med. 185:1997;393.
62. D'Ambrosio D., Hippen K.L., Minskoff S.A., Mellman I., Pani G., Siminovitch K.A., Cambier J.C. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science. 268:1995;293.
63. Peruzzi M., Parker K.C., Long E.O., Malnati M.S. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J Immunol. 157:1996;3350.
64. Rajagopalan S., Long E.O. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med. 185:1997;1523.
65. Kim J., Chwae Y.J., Kim M.Y., Choi I.H., Park J.H., Kim S.J. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors. J Immunol. 159:1997;3875.
66. Aramburu J., Balboa M.A., Ramirez A., Silva A., Acevedo A., Sanchez-Madrid F., De Landazuri M.O., Lopez-Botet M. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-g/d+ T lymphocytes. I. Inhibition of the IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J Immunol. 144:1990;3238.
67. Aramburu J., Balboa M.A., Izquierdo M., Lopez-Botet M. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-g/d+ T lymphocytes. II. Modulation of natural killer cell cytotoxicity by anti-Kp43 monoclonal antibody. J Immunol. 147:1991;714.
68. Brooks A.G., Posch P.E., Scorzelli C.J., Borrego F., Coligan J.E. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J Exp Med. 185:1997;795.
69. Carretero M., Cantoni C., Bellon T., Bottino C., Biassoni R., Rodriguez A., Perez-Villar J.J., Moretta L., Moretta A., Lopez-Botet M. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol. 27:1997;563.
70. Lazetic S., Chang C., Houchins J.P., Lanier L.L., Phillips J.H. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol. 157:1996;4741.
71. Le Drean E., Vely F., Olcese L., Cambiaggi A., Guia S., Krystal G., Gervois N., Moretta A., Jotereau F., Vivier E. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases . Eur J Immunol. 28:1998;264.
72. Lanier L.L., Corliss B., Wu J., Phillips J.H. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity. 8:1998;693.
73. Moretta A., Vitale M., Sivori S., Bottino C., Morelli L., Augugliaro R., Barbaresi M., Pende D., Ciccone E., Lopez-Botet M., et al. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med. 180:1994;545.
74. Phillips J.H., Chang C., Mattson J., Gumperz J.E., Parham P., Lanier L.L. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity. 5:1996;163.
75. Sivori S., Vitale M., Bottino C., Marcenaro E., Sanseverino L., Parolini S., Moretta L., Moretta A. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies . Eur J Immunol. 26:1996;2487.
76. Braud V., Jones E.Y., McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol. 27:1997;1164.
77. Lee N.J., Goodlett D.R., Ishitani A., Marquardt H., Geraghty D.E. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. Immunology. 160:1998;4951.
78. Llano M., Lee N., Navarro F., Garcia P., Albar J.P., Geraghty D.E., Lopez-Botet M. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors preferential response to an HLA-G-derived nonamer . Eur J Immunol. 28:1998;2854.
79. Brooks A.G., Borrego F., Posch P.E., Patamawenu A., Scorzelli C.J., Ulbrecht M., Weiss E.H., Coligan J.E. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J Immunol. 162:1998;305.
80. Vales-Gomez M., Reyburn H.T., Erskine R.A., Lopez-Botet M., Strominger J.L. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 18:1999;4250.
81. Ulbrecht M.J., Modrow S., Srivastava R., Peterson P.A., Weiss E.H. Interaction of HLA-E with peptides and the peptide transporter in vitro implications for its function in antigen presentation . J Immunology. 160:1998;4374.
82. Braud V.M., Allan D.S.J., Wilson D., McMichael A.J. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol. 8:1998;1.
83. Furukawa T., Yabe T., Akaza T., Tadokoro K., Tohma S., Inoue T., Tokunaga K., Yamamoto K., Geraghty D.E., Juji T. Cell surface expression of HLA-E molecules on PBMC from a TAP1-deficient patient. Tissue Antigens. 53:1999;292.
84. Bai A.G., Broen J., Forman J. The pathway for processing leader-derived peptides that regulate the maturation and expression of Qa-1b. Immunity. 9:1998;413.
85. Dustin M.L., Golan D.E., Shu D.M., Miller J.M., Meier W., Davies E.A., van der Merwe P.A. Low affinity interaction of human or rat T cell adhesion molecule CD2 with its ligand aligns adhering membranes to achieve high physiological affinity. J Biol Chem. 272:1997;30889.
86. Garcia K.C., Scott C.A., Brunmark A., Carbone F.R., Peterson P.A., Wilson I.A., Teyton L. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature. 384:(6609):1996;577. [see comments].
87. Matsui K., Boniface J., Reay P., Schild H., de-St-Groth B., Davis M. Low affinity interaction of peptide-MHC complexes with T cell receptors. Science. 254:1992;1788.
88. Roggenbuck D., Konig H., Niemann B., Schoenher G., Jahn S., Portsmann T. Real-time biospecific interaction analysis of a natural human polyreactive monoclonal IgM antibody and its Fab and scFv fragments with several antigens. Scand J Immunol. 40:(1):1994;64.
89. Karlsson R., Michaelsson A., Mattsson L. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J Immunol Methods. 145:(1-2):1991;229.
90. van der Merwe P.A., Barclay A.N., Mason D.W., Davies E.A., Morgan B.P., Tone M., Krishnam A.K., Ianelli C., Davis S.J. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry. 33:(33):1994;10149.
91. van der Merwe P.A., Brown M.H., Davis S.J., Barclay A.N. Affinity and kinetic analysis of the interaction of the cell adhesion molecules rat CD2 and CD48. EMBO J. 12:(13):1993;4945.